Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898222 · ClinicalTrials.gov registry record · NA
Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00898222 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4 participants.
The verdict
NCT00898222, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.
Interventions
- DRUG aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898222
The ClinicalTrials.gov registry entry for NCT00898222 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which aspirin is the first listed.
NCT00898222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898222 about?
NCT00898222 is a clinical study titled "Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects". Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.
What is the current status of trial NCT00898222?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2009-05. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00898222?
The interventions under investigation include: aspirin (DRUG).
Who is sponsoring clinical trial NCT00898222?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.